Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

[Effects of E23K polymorphism in KCNJ11 gene on membrane current].

Xia XH, Yang AH, Hu Y.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2014 Jan;30(1):23-6. Chinese.

PMID:
24741969
2.

The KCNJ11 E23K gene polymorphism and type 2 diabetes mellitus in the Chinese Han population: a meta-analysis of 6,109 subjects.

Li YY.

Mol Biol Rep. 2013 Jan;40(1):141-6. doi: 10.1007/s11033-012-2042-9. Epub 2012 Oct 11.

PMID:
23054005
3.

Lack of genetic susceptibility of KCNJ11 E23K polymorphism with risk of type 2 diabetes in an Iranian population.

Keshavarz P, Habibipour R, Ghasemi M, Kazemnezhad E, Alizadeh M, Omami MH.

Endocr Res. 2014;39(3):120-5. doi: 10.3109/07435800.2013.860607. Epub 2014 Jan 24.

PMID:
24460047
4.

Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated type 2 diabetic patients.

Ragia G, Tavridou A, Petridis I, Manolopoulos VG.

Diabetes Res Clin Pract. 2012 Oct;98(1):119-24. doi: 10.1016/j.diabres.2012.04.017. Epub 2012 May 14.

PMID:
22591706
5.

Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.

Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, McCarthy MI, Hattersley AT, Frayling TM.

Diabetes. 2003 Feb;52(2):568-72.

6.

Gene-gene interactions between HNF4A and KCNJ11 in predicting Type 2 diabetes in women.

Qi L, van Dam RM, Asselbergs FW, Hu FB.

Diabet Med. 2007 Nov;24(11):1187-91. Epub 2007 Sep 26.

PMID:
17894829
7.

Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus.

Shaat N, Ekelund M, Lernmark A, Ivarsson S, Almgren P, Berntorp K, Groop L.

Diabetologia. 2005 Dec;48(12):2544-51. Epub 2005 Nov 17.

PMID:
16320083
8.

E23K polymorphism of the KCNJ11 gene in Korean children with type 1 diabetes.

Ko JM, Yang S, Kim SY, Lee HS, Hwang JS, Hwang IT.

World J Pediatr. 2012 May;8(2):169-72. doi: 10.1007/s12519-012-0355-3. Epub 2012 May 10.

PMID:
22573428
9.

Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.

Barber TM, Bennett AJ, Gloyn AL, Groves CJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Taponen S, Weedon MN, Hartikainen AL, Wass JA, Järvelin MR, Zeggini E, Franks S, McCarthy MI.

Eur J Hum Genet. 2007 Jun;15(6):679-84. Epub 2007 Mar 7.

10.

KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.

Javorsky M, Klimcakova L, Schroner Z, Zidzik J, Babjakova E, Fabianova M, Kozarova M, Tkacova R, Salagovic J, Tkac I.

Eur J Intern Med. 2012 Apr;23(3):245-9. doi: 10.1016/j.ejim.2011.10.018. Epub 2011 Nov 26.

PMID:
22385882
11.
12.

E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population.

Abdelhamid I, Lasram K, Meiloud G, Ben Halim N, Kefi R, Samb A, Abdelhak S, Houmeida A.

Prim Care Diabetes. 2014 Jul;8(2):171-5. doi: 10.1016/j.pcd.2013.10.006. Epub 2013 Dec 12.

PMID:
24332549
13.

The KCNJ11 E23K polymorphism and progression of glycaemia in Southern Chinese: a long-term prospective study.

Cheung CY, Tso AW, Cheung BM, Xu A, Fong CH, Ong KL, Law LS, Wat NM, Janus ED, Sham PC, Lam KS.

PLoS One. 2011;6(12):e28598. doi: 10.1371/journal.pone.0028598. Epub 2011 Dec 5.

14.

Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.

Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Nathan DM, Altshuler D.

Diabetes. 2007 Feb;56(2):531-6.

15.

Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.

He YY, Zhang R, Shao XY, Hu C, Wang CR, Lu JX, Bao YQ, Jia WP, Xiang KS.

Acta Pharmacol Sin. 2008 Aug;29(8):983-9. doi: 10.1111/j.1745-7254.2008.00840.x.

16.

The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.

Holstein A, Hahn M, Stumvoll M, Kovacs P.

Horm Metab Res. 2009 May;41(5):387-90. doi: 10.1055/s-0029-1192019. Epub 2009 Feb 12.

PMID:
19214942
17.

The E23K and A190A variations of the KCNJ11 gene are associated with early-onset type 2 diabetes and blood pressure in the Chinese population.

Zhuang L, Zhao Y, Zhao W, Li M, Yu M, Lu M, Zhang R, Ge X, Zheng T, Li C, Yin J, Yin J, Bao Y, Liu L, Jia W, Liu Y.

Mol Cell Biochem. 2015 Jun;404(1-2):133-41. doi: 10.1007/s11010-015-2373-7. Epub 2015 Mar 1.

PMID:
25725792
18.

Association of KCNJ11 (E23K) gene polymorphism with susceptibility to type 2 diabetes in Iranian patients.

Rastegari A, Rabbani M, Sadeghi HM, Imani EF, Hasanzadeh A, Moazen F.

Adv Biomed Res. 2015 Jan 6;4:1. doi: 10.4103/2277-9175.148256. eCollection 2015.

19.

Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.

Hamming KS, Soliman D, Matemisz LC, Niazi O, Lang Y, Gloyn AL, Light PE.

Diabetes. 2009 Oct;58(10):2419-24. doi: 10.2337/db09-0143. Epub 2009 Jul 8.

20.

Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome.

Christopoulos P, Mastorakos G, Gazouli M, Panidis D, Deligeoroglou E, Katsikis I, Papadias K, Diamandi-Kandarakis E, Creatsas G.

Gynecol Endocrinol. 2008 Sep;24(9):486-90. doi: 10.1080/09513590802196379.

PMID:
18958766
Items per page

Supplemental Content

Write to the Help Desk